 |
市場調查報告書
商品編碼
1801431
轉化生長因子β1市場報告：趨勢、預測與競爭分析（至2031年）Transforming Growth Factor Beta 1 Market Report: Trends, Forecast and Competitive Analysis to 2031 |
||||||
價格
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球轉化生長因子β1市場前景光明，得益於特發性肺纖維化（IPF）和癌症市場的機會。預計2025年至2031年期間，全球轉化生長因子β1市場將以9.7%的年複合成長率成長。該市場的主要驅動力包括：對其在癌症治療藥物中應用的研究不斷增加、全球纖維化疾病盛行率的上升，以及對生物製藥開發的投資不斷增加。
- Lucintel 預測，在預測期內，Pirfenidone將在所有藥物類別中實現最高的成長率。
- 從應用來看，腫瘤學預計將經歷更高的成長。
- 依地區分類，預計亞太地區將在預測期內實現最高成長。
轉化生長因子β1市場的新趨勢
隨著生物技術的進步、臨床研究的不斷深入以及疾病治療應用的不斷拓展，轉化生長因子β1市場不斷發展。新興趨勢推動技術創新，並擴大市場潛力。
- 纖維化治療日益受到關注：研發人員開發利用轉化生長因子β1治療纖維化疾病的標靶治療。這一趨勢拓展肝纖維化和肺纖維化等疾病的治療選擇。
- 癌症免疫療法中的作用日益擴大：轉化生長因子β1正被研究作為癌症治療的靶點，同時新的抑制劑也研發中，以增強免疫療法的有效性。這項研究或將催生新的抗癌藥物。
- 再生醫學的進展：轉化生長因子-BETA1在組織工程和幹細胞治療的應用日益廣泛。它在創傷治療和器官再生中發揮著重要作用。
- 精準醫療的應用不斷擴大：包括調節轉化生長因子-BETA1的個人化治療出現，研究人員探索其在客製化自體免疫和發炎疾病治療方法中的作用。
- 政府和私營部門的資金投入增加：生物技術研究投資的增加加速藥物研發。政府和私人企業資助探索新醫療應用的計劃。
這些趨勢透過擴大治療應用和提高治療精度重塑轉化生長因子β1市場，持續的研究和投資預計將推動進一步的技術創新。
轉化生長因子β1市場的最新趨勢
轉化生長因子β1市場在臨床研究、藥物開發和監管核准方面取得重大進展。這些發展塑造治療應用的未來。
- 抗癌藥物的進展：研發人員開發轉化生長因子β1抑制劑，以增強免疫療法。這些進展改善癌症治療效果。
- 纖維化治療研究取得進展：針對轉化生長因子β1的藥物進行針對肺纖維化和肝纖維化的臨床試驗，為治療提供了新的可能性。
- 拓展再生醫學的應用：探討轉化生長因子β1在幹細胞治療和組織再生中的作用，推動醫學創新。
- 增加臨床試驗的監管核准：政府和衛生當局支持轉化生長因子β1的研究，帶來更多的臨床試驗和新藥核准。
- 擴大生物技術公司和大學之間的合作：產業合作夥伴關係加速轉化生長因子-BETA1治療方法的研究並促進創新。
這些市場發展透過擴大治療應用和加速藥物核准來改變轉化生長因子β1市場。增加研究資金和合作研究推動市場成長。
目錄
第1章 執行摘要
第2章 市場概述
- 背景和分類
- 供應鏈
第3章 市場趨勢與預測分析
- 宏觀經濟趨勢與預測
- 產業驅動力與挑戰
- PESTLE分析
- 專利分析
- 法規環境
第4章 全球轉化生長因子β1市場（依類型）
- 概述
- 吸引力分析：依類型
- Pirfenidone：趨勢與預測（2019-2031）
- Galunisertib：趨勢與預測（2019-2031）
- 其他：趨勢與預測（2019-2031）
第5章 全球轉化生長因子β1市場（依應用）
- 概述
- 吸引力分析：依用途
- IPF：趨勢與預測（2019-2031）
- 癌症：趨勢與預測（2019-2031）
- 其他：趨勢與預測（2019-2031）
第6章 區域分析
- 概述
- 全球轉換成長因子BETA1市場（依地區）
第7章 北美轉化生長因子β1市場
- 概述
- 北美轉化生長因子β1市場（依類型）
- 北美轉化生長因子β1市場（依應用）
- 美國轉化生長因子β1市場
- 墨西哥轉化生長因子β1市場
- 加拿大轉化生長因子β1市場
第8章 歐洲轉化生長因子β1市場
- 概述
- 歐洲轉化生長因子β1市場（依類型）
- 歐洲轉化生長因子β1市場（依應用）
- 德國轉化生長因子β1市場
- 法國轉化生長因子β1市場
- 西班牙轉化生長因子β1市場
- 義大利轉化生長因子β1市場
- 英國轉化生長因子β1市場
第9章 亞太地區轉化生長因子β1市場
- 概述
- 亞太地區轉化生長因子β1市場（依類型）
- 亞太地區轉化生長因子β1市場（依應用）
- 日本轉化生長因子β1市場
- 印度轉化生長因子β1市場
- 中國轉化生長因子β1市場
- 韓國轉化生長因子β1市場
- 印尼轉化生長因子β1市場
第10章 其他地區（ROW）的轉化生長因子β1市場
- 概述
- 世界其他地區（ROW）轉化生長因子β1市場（依類型）
- 世界其他地區（ROW）轉化生長因子β1市場（依應用）
- 中東轉化生長因子β1市場
- 南美洲轉化生長因子β1市場
- 非洲轉化生長因子β1市場
第11章 競爭分析
- 產品系列分析
- 運作整合
- 波特五力分析
- 競爭敵對
- 買方議價能力
- 供應商的議價能力
- 替代品的威脅
- 新進入者的威脅
- 市場佔有率分析
第12章 機會與策略分析
- 價值鏈分析
- 成長機會分析
- 成長機會：依類型
- 成長機會：依應用
- 全球轉換成長因子BETA1市場新興趨勢
- 戰略分析
- 新產品開發
- 認證和許可
- 企業合併（M&A）、協議、合作與合資企業
第13章 價值鏈主要企業概況
- 競爭分析
- Roche
- Shionogi
- Acceleron Pharma
- Genzyme
- Isarna Therapeutics
- Scholar Rock
- Sirnaomics
第14章 附錄
- 圖片列表
- 表格列表
- 分析方法
- 免責聲明
- 版權
- 簡稱和技術單位
- 關於 Lucintel
- 詢問
The future of the global transforming growth factor beta 1 market looks promising with opportunities in the IPF and cancer markets. The global transforming growth factor beta 1 market is expected to grow with a CAGR of 9.7% from 2025 to 2031. The major drivers for this market are the increasing research in cancer therapeutics applications, the rising prevalence of fibrotic diseases globally, and the growing investment in biotechnology drug development.
- Lucintel forecasts that, within the type category, pirfenidone is expected to witness higher growth over the forecast period.
- Within the application category, cancer is expected to witness higher growth.
- In terms of region, APAC is expected to witness the highest growth over the forecast period.
Emerging Trends in the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market is evolving with advancements in biotechnology, increased clinical research, and growing applications in disease treatment. Emerging trends are driving innovation and expanding market potential.
- Increased Focus on Fibrosis Treatment: Researchers are developing targeted therapies using transforming growth factor beta 1 to manage fibrotic diseases. This trend is expanding treatment options for conditions such as liver fibrosis and pulmonary fibrosis.
- Growing Role in Cancer Immunotherapy: Transforming growth factor beta 1 is being explored as a target in cancer treatment, with new inhibitors being developed to improve immunotherapy effectiveness. This research is leading to new oncology drugs.
- Advancements in Regenerative Medicine: The use of transforming growth factor beta 1 in tissue engineering and stem cell therapy is growing. It is playing a crucial role in wound healing and organ regeneration.
- Expansion in Precision Medicine Applications: Personalized therapies involving transforming growth factor beta 1 modulation are emerging. Researchers are exploring its role in tailoring treatments for autoimmune and inflammatory diseases.
- Increasing Government and Private Sector Funding: Rising investments in biotechnology research are accelerating drug development. Governments and private firms are funding projects to explore new medical applications.
These trends are reshaping the transforming growth factor beta 1 market by expanding its therapeutic applications and enhancing treatment precision. Continued research and investment are expected to drive further innovations.
Recent Developments in the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market is experiencing significant advancements in clinical research, drug development, and regulatory approvals. These developments are shaping the future of therapeutic applications.
- Advancement in Cancer Therapeutics: Researchers are developing transforming growth factor beta 1 inhibitors to enhance immunotherapy. These advancements are improving cancer treatment outcomes.
- Progress in Fibrosis Treatment Research: Clinical trials are evaluating transforming growth factor beta 1-targeted drugs for pulmonary and liver fibrosis, offering new treatment possibilities.
- Expansion of Regenerative Medicine Applications: Scientists are exploring transforming growth factor beta 1's role in stem cell therapy and tissue regeneration, advancing medical innovation.
- Increased Regulatory Approvals for Clinical Trials: Governments and health authorities are supporting research on transforming growth factor beta 1, leading to more clinical trials and new drug approvals.
- Growing Collaborations Between Biotech Companies and Universities: Industry partnerships are accelerating research, driving innovation in transforming growth factor beta 1-based therapies.
These developments are transforming the transforming growth factor beta 1 market by expanding its therapeutic applications and accelerating drug approvals. Increased research funding and collaborations are driving market growth.
Strategic Growth Opportunities in the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market presents significant growth opportunities across various applications. Advancements in regenerative medicine, oncology, and fibrosis treatment are creating new possibilities for market expansion.
- Development of Anti-Fibrotic Therapies: The rising prevalence of fibrotic diseases is driving demand for transforming growth factor beta 1 inhibitors, offering new market opportunities in pulmonary and liver fibrosis treatment.
- Expansion in Cancer Immunotherapy Research: Transforming growth factor beta 1 modulation is improving immunotherapy outcomes, creating opportunities for new oncology drug development.
- Advancements in Stem Cell Therapy Applications: The integration of transforming growth factor beta 1 in stem cell-based treatments is enhancing wound healing and tissue regeneration.
- Increasing Use in Autoimmune Disease Treatment: Researchers are exploring the role of transforming growth factor beta 1 in regulating immune responses, creating growth potential in autoimmune therapy.
- Growing Investment in Personalized Medicine: The role of transforming growth factor beta 1 in precision medicine is expanding, allowing for the development of targeted therapies for specific patient populations.
These growth opportunities highlight the expanding role of transforming growth factor beta 1 in modern medicine. Continued research and investment are expected to drive innovation and broaden its therapeutic applications.
Transforming Growth Factor Beta 1 Market Driver and Challenges
The transforming growth factor beta 1 market is influenced by various drivers and challenges, including advancements in medical research, regulatory policies, and economic factors. These elements shape the market's growth and application potential.
The factors responsible for driving the transforming growth factor beta 1 market include:
1. Rising Demand for Regenerative Medicine: Increasing interest in tissue engineering and stem cell therapy is driving the demand for transforming growth factor beta 1 in regenerative medicine applications.
2. Growing Investments in Oncology Research: Pharmaceutical companies are funding research on transforming growth factor beta 1 inhibitors for cancer treatment, expanding market opportunities.
3. Advancements in Drug Development Technologies: Innovations in biotechnology are enabling the development of targeted therapies using transforming growth factor beta 1, improving treatment effectiveness.
4. Supportive Government Policies for Biotechnology Research: Governments worldwide are funding biotechnology projects, accelerating research on transforming growth factor beta 1 applications.
5. Expansion of Clinical Trials in Fibrosis and Cancer Therapy: Increasing clinical trials exploring transforming growth factor beta 1's role in disease treatment are driving market growth and drug development.
Challenges in the transforming growth factor beta 1 market are:
1. Regulatory Complexities and Approval Delays: The stringent approval process for new transforming growth factor beta 1 therapies poses a challenge to market entry and commercialization.
2. High Research and Development Costs: The cost-intensive nature of transforming growth factor beta 1 research limits investment by smaller biotech firms, slowing market expansion.
3. Potential Side Effects and Safety Concerns: Managing the adverse effects of transforming growth factor beta 1 modulation in therapeutic applications remains a significant challenge in drug development.
The transforming growth factor beta 1 market is growing due to increased research, regulatory support, and advancements in medical applications. However, challenges such as regulatory hurdles, high costs, and safety concerns must be addressed for sustained market growth.
List of Transforming Growth Factor Beta 1 Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transforming growth factor beta 1 companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transforming growth factor beta 1 companies profiled in this report include-
- Roche
- Shionogi
- Acceleron Pharma
- Genzyme
- Isarna Therapeutics
- Scholar Rock
- Sirnaomics
Transforming Growth Factor Beta 1 Market by Segment
The study includes a forecast for the global transforming growth factor beta 1 market by type, application, and region.
Transforming Growth Factor Beta 1 Market by Type [Value from 2019 to 2031]:
- Pirfenidone
- Galunisertib
- Others
Transforming Growth Factor Beta 1 Market by Application [Value from 2019 to 2031]:
- IPF
- Cancer
- Others
Transforming Growth Factor Beta 1 Market by Region [Value from 2019 to 2031]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market is evolving with advancements in biotechnology, increased clinical research, and growing applications in disease treatment. Emerging trends are driving innovation and expanding market potential.
- Increased Focus on Fibrosis Treatment: Researchers are developing targeted therapies using transforming growth factor beta 1 to manage fibrotic diseases. This trend is expanding treatment options for conditions such as liver fibrosis and pulmonary fibrosis.
- Growing Role in Cancer Immunotherapy: Transforming growth factor beta 1 is being explored as a target in cancer treatment, with new inhibitors being developed to improve immunotherapy effectiveness. This research is leading to new oncology drugs.
- Advancements in Regenerative Medicine: The use of transforming growth factor beta 1 in tissue engineering and stem cell therapy is growing. It is playing a crucial role in wound healing and organ regeneration.
- Expansion in Precision Medicine Applications: Personalized therapies involving transforming growth factor beta 1 modulation are emerging. Researchers are exploring its role in tailoring treatments for autoimmune and inflammatory diseases.
- Increasing Government and Private Sector Funding: Rising investments in biotechnology research are accelerating drug development. Governments and private firms are funding projects to explore new medical applications.
Features of the Global Transforming Growth Factor Beta 1 Market
- Market Size Estimates: Transforming growth factor beta 1 market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
- Segmentation Analysis: Transforming growth factor beta 1 market size by type, application, and region in terms of value ($B).
- Regional Analysis: Transforming growth factor beta 1 market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the transforming growth factor beta 1 market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transforming growth factor beta 1 market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the transforming growth factor beta 1 market by type (pirfenidone, galunisertib, and others), application (IPF, cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
- 2.1 Background and Classifications
- 2.2 Supply Chain
3. Market Trends & Forecast Analysis
- 3.1 Macroeconomic Trends and Forecasts
- 3.2 Industry Drivers and Challenges
- 3.3 PESTLE Analysis
- 3.4 Patent Analysis
- 3.5 Regulatory Environment
4. Global Transforming Growth Factor Beta 1 Market by Type
- 4.1 Overview
- 4.2 Attractiveness Analysis by Type
- 4.3 Pirfenidone: Trends and Forecast (2019-2031)
- 4.4 Galunisertib: Trends and Forecast (2019-2031)
- 4.5 Others: Trends and Forecast (2019-2031)
5. Global Transforming Growth Factor Beta 1 Market by Application
- 5.1 Overview
- 5.2 Attractiveness Analysis by Application
- 5.3 IPF: Trends and Forecast (2019-2031)
- 5.4 Cancer: Trends and Forecast (2019-2031)
- 5.5 Others: Trends and Forecast (2019-2031)
6. Regional Analysis
- 6.1 Overview
- 6.2 Global Transforming Growth Factor Beta 1 Market by Region
7. North American Transforming Growth Factor Beta 1 Market
- 7.1 Overview
- 7.2 North American Transforming Growth Factor Beta 1 Market by Type
- 7.3 North American Transforming Growth Factor Beta 1 Market by Application
- 7.4 United States Transforming Growth Factor Beta 1 Market
- 7.5 Mexican Transforming Growth Factor Beta 1 Market
- 7.6 Canadian Transforming Growth Factor Beta 1 Market
8. European Transforming Growth Factor Beta 1 Market
- 8.1 Overview
- 8.2 European Transforming Growth Factor Beta 1 Market by Type
- 8.3 European Transforming Growth Factor Beta 1 Market by Application
- 8.4 German Transforming Growth Factor Beta 1 Market
- 8.5 French Transforming Growth Factor Beta 1 Market
- 8.6 Spanish Transforming Growth Factor Beta 1 Market
- 8.7 Italian Transforming Growth Factor Beta 1 Market
- 8.8 United Kingdom Transforming Growth Factor Beta 1 Market
9. APAC Transforming Growth Factor Beta 1 Market
- 9.1 Overview
- 9.2 APAC Transforming Growth Factor Beta 1 Market by Type
- 9.3 APAC Transforming Growth Factor Beta 1 Market by Application
- 9.4 Japanese Transforming Growth Factor Beta 1 Market
- 9.5 Indian Transforming Growth Factor Beta 1 Market
- 9.6 Chinese Transforming Growth Factor Beta 1 Market
- 9.7 South Korean Transforming Growth Factor Beta 1 Market
- 9.8 Indonesian Transforming Growth Factor Beta 1 Market
10. ROW Transforming Growth Factor Beta 1 Market
- 10.1 Overview
- 10.2 ROW Transforming Growth Factor Beta 1 Market by Type
- 10.3 ROW Transforming Growth Factor Beta 1 Market by Application
- 10.4 Middle Eastern Transforming Growth Factor Beta 1 Market
- 10.5 South American Transforming Growth Factor Beta 1 Market
- 10.6 African Transforming Growth Factor Beta 1 Market
11. Competitor Analysis
- 11.1 Product Portfolio Analysis
- 11.2 Operational Integration
- 11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
- 11.4 Market Share Analysis
12. Opportunities & Strategic Analysis
- 12.1 Value Chain Analysis
- 12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
- 12.3 Emerging Trends in the Global Transforming Growth Factor Beta 1 Market
- 12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures
13. Company Profiles of the Leading Players Across the Value Chain
- 13.1 Competitive Analysis
- 13.2 Roche
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.3 Shionogi
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.4 Acceleron Pharma
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.5 Genzyme
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.6 Isarna Therapeutics
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.7 Scholar Rock
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.8 Sirnaomics
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14. Appendix
- 14.1 List of Figures
- 14.2 List of Tables
- 14.3 Research Methodology
- 14.4 Disclaimer
- 14.5 Copyright
- 14.6 Abbreviations and Technical Units
- 14.7 About Us
- 14.8 Contact Us
List of Figures
- Figure 1.1: Trends and Forecast for the Global Transforming Growth Factor Beta 1 Market
- Figure 2.1: Usage of Transforming Growth Factor Beta 1 Market
- Figure 2.2: Classification of the Global Transforming Growth Factor Beta 1 Market
- Figure 2.3: Supply Chain of the Global Transforming Growth Factor Beta 1 Market
- Figure 2.4: Driver and Challenges of the Transforming Growth Factor Beta 1 Market
- Figure 3.1: Trends of the Global GDP Growth Rate
- Figure 3.2: Trends of the Global Population Growth Rate
- Figure 3.3: Trends of the Global Inflation Rate
- Figure 3.4: Trends of the Global Unemployment Rate
- Figure 3.5: Trends of the Regional GDP Growth Rate
- Figure 3.6: Trends of the Regional Population Growth Rate
- Figure 3.7: Trends of the Regional Inflation Rate
- Figure 3.8: Trends of the Regional Unemployment Rate
- Figure 3.9: Trends of Regional Per Capita Income
- Figure 3.10: Forecast for the Global GDP Growth Rate
- Figure 3.11: Forecast for the Global Population Growth Rate
- Figure 3.12: Forecast for the Global Inflation Rate
- Figure 3.13: Forecast for the Global Unemployment Rate
- Figure 3.14: Forecast for the Regional GDP Growth Rate
- Figure 3.15: Forecast for the Regional Population Growth Rate
- Figure 3.16: Forecast for the Regional Inflation Rate
- Figure 3.17: Forecast for the Regional Unemployment Rate
- Figure 3.18: Forecast for Regional Per Capita Income
- Figure 4.1: Global Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
- Figure 4.2: Trends of the Global Transforming Growth Factor Beta 1 Market ($B) by Type
- Figure 4.3: Forecast for the Global Transforming Growth Factor Beta 1 Market ($B) by Type
- Figure 4.4: Trends and Forecast for Pirfenidone in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 4.5: Trends and Forecast for Galunisertib in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 4.6: Trends and Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 5.1: Global Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
- Figure 5.2: Trends of the Global Transforming Growth Factor Beta 1 Market ($B) by Application
- Figure 5.3: Forecast for the Global Transforming Growth Factor Beta 1 Market ($B) by Application
- Figure 5.4: Trends and Forecast for IPF in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 5.5: Trends and Forecast for Cancer in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 5.6: Trends and Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 6.1: Trends of the Global Transforming Growth Factor Beta 1 Market ($B) by Region (2019-2024)
- Figure 6.2: Forecast for the Global Transforming Growth Factor Beta 1 Market ($B) by Region (2025-2031)
- Figure 7.1: Trends and Forecast for the North American Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 7.2: North American Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
- Figure 7.3: Trends of the North American Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
- Figure 7.4: Forecast for the North American Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
- Figure 7.5: North American Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
- Figure 7.6: Trends of the North American Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
- Figure 7.7: Forecast for the North American Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
- Figure 7.8: Trends and Forecast for the United States Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 7.9: Trends and Forecast for the Mexican Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 7.10: Trends and Forecast for the Canadian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 8.1: Trends and Forecast for the European Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 8.2: European Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
- Figure 8.3: Trends of the European Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
- Figure 8.4: Forecast for the European Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
- Figure 8.5: European Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
- Figure 8.6: Trends of the European Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
- Figure 8.7: Forecast for the European Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
- Figure 8.8: Trends and Forecast for the German Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 8.9: Trends and Forecast for the French Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 8.10: Trends and Forecast for the Spanish Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 8.11: Trends and Forecast for the Italian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 8.12: Trends and Forecast for the United Kingdom Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 9.1: Trends and Forecast for the APAC Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 9.2: APAC Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
- Figure 9.3: Trends of the APAC Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
- Figure 9.4: Forecast for the APAC Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
- Figure 9.5: APAC Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
- Figure 9.6: Trends of the APAC Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
- Figure 9.7: Forecast for the APAC Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
- Figure 9.8: Trends and Forecast for the Japanese Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 9.9: Trends and Forecast for the Indian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 9.10: Trends and Forecast for the Chinese Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 9.11: Trends and Forecast for the South Korean Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 9.12: Trends and Forecast for the Indonesian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 10.1: Trends and Forecast for the ROW Transforming Growth Factor Beta 1 Market (2019-2031)
- Figure 10.2: ROW Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
- Figure 10.3: Trends of the ROW Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
- Figure 10.4: Forecast for the ROW Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
- Figure 10.5: ROW Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
- Figure 10.6: Trends of the ROW Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
- Figure 10.7: Forecast for the ROW Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
- Figure 10.8: Trends and Forecast for the Middle Eastern Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 10.9: Trends and Forecast for the South American Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 10.10: Trends and Forecast for the African Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
- Figure 11.1: Porter's Five Forces Analysis of the Global Transforming Growth Factor Beta 1 Market
- Figure 11.2: Market Share (%) of Top Players in the Global Transforming Growth Factor Beta 1 Market (2024)
- Figure 12.1: Growth Opportunities for the Global Transforming Growth Factor Beta 1 Market by Type
- Figure 12.2: Growth Opportunities for the Global Transforming Growth Factor Beta 1 Market by Application
- Figure 12.3: Growth Opportunities for the Global Transforming Growth Factor Beta 1 Market by Region
- Figure 12.4: Emerging Trends in the Global Transforming Growth Factor Beta 1 Market
List of Tables
- Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Transforming Growth Factor Beta 1 Market by Type and Application
- Table 1.2: Attractiveness Analysis for the Transforming Growth Factor Beta 1 Market by Region
- Table 1.3: Global Transforming Growth Factor Beta 1 Market Parameters and Attributes
- Table 3.1: Trends of the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 3.2: Forecast for the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 4.1: Attractiveness Analysis for the Global Transforming Growth Factor Beta 1 Market by Type
- Table 4.2: Market Size and CAGR of Various Type in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 4.3: Market Size and CAGR of Various Type in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 4.4: Trends of Pirfenidone in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 4.5: Forecast for Pirfenidone in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 4.6: Trends of Galunisertib in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 4.7: Forecast for Galunisertib in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 4.8: Trends of Others in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 4.9: Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 5.1: Attractiveness Analysis for the Global Transforming Growth Factor Beta 1 Market by Application
- Table 5.2: Market Size and CAGR of Various Application in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 5.3: Market Size and CAGR of Various Application in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 5.4: Trends of IPF in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 5.5: Forecast for IPF in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 5.6: Trends of Cancer in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 5.7: Forecast for Cancer in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 5.8: Trends of Others in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 5.9: Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 6.1: Market Size and CAGR of Various Regions in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 6.2: Market Size and CAGR of Various Regions in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 7.1: Trends of the North American Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 7.2: Forecast for the North American Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 7.3: Market Size and CAGR of Various Type in the North American Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 7.4: Market Size and CAGR of Various Type in the North American Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 7.5: Market Size and CAGR of Various Application in the North American Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 7.6: Market Size and CAGR of Various Application in the North American Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 7.7: Trends and Forecast for the United States Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 7.8: Trends and Forecast for the Mexican Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 7.9: Trends and Forecast for the Canadian Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 8.1: Trends of the European Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 8.2: Forecast for the European Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 8.3: Market Size and CAGR of Various Type in the European Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 8.4: Market Size and CAGR of Various Type in the European Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 8.5: Market Size and CAGR of Various Application in the European Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 8.6: Market Size and CAGR of Various Application in the European Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 8.7: Trends and Forecast for the German Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 8.8: Trends and Forecast for the French Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 8.9: Trends and Forecast for the Spanish Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 8.10: Trends and Forecast for the Italian Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 8.11: Trends and Forecast for the United Kingdom Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 9.1: Trends of the APAC Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 9.2: Forecast for the APAC Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 9.3: Market Size and CAGR of Various Type in the APAC Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 9.4: Market Size and CAGR of Various Type in the APAC Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 9.5: Market Size and CAGR of Various Application in the APAC Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 9.6: Market Size and CAGR of Various Application in the APAC Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 9.7: Trends and Forecast for the Japanese Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 9.8: Trends and Forecast for the Indian Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 9.9: Trends and Forecast for the Chinese Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 9.10: Trends and Forecast for the South Korean Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 9.11: Trends and Forecast for the Indonesian Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 10.1: Trends of the ROW Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 10.2: Forecast for the ROW Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 10.3: Market Size and CAGR of Various Type in the ROW Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 10.4: Market Size and CAGR of Various Type in the ROW Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 10.5: Market Size and CAGR of Various Application in the ROW Transforming Growth Factor Beta 1 Market (2019-2024)
- Table 10.6: Market Size and CAGR of Various Application in the ROW Transforming Growth Factor Beta 1 Market (2025-2031)
- Table 10.7: Trends and Forecast for the Middle Eastern Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 10.8: Trends and Forecast for the South American Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 10.9: Trends and Forecast for the African Transforming Growth Factor Beta 1 Market (2019-2031)
- Table 11.1: Product Mapping of Transforming Growth Factor Beta 1 Suppliers Based on Segments
- Table 11.2: Operational Integration of Transforming Growth Factor Beta 1 Manufacturers
- Table 11.3: Rankings of Suppliers Based on Transforming Growth Factor Beta 1 Revenue
- Table 12.1: New Product Launches by Major Transforming Growth Factor Beta 1 Producers (2019-2024)
- Table 12.2: Certification Acquired by Major Competitor in the Global Transforming Growth Factor Beta 1 Market
02-2729-4219
+886-2-2729-4219
